1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Rupture in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berndt, MC; Bobik, A; Jennings, G; Kannelakis, P; Taylor, AJ | 1 |
1 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Rupture
| Article | Year |
|---|---|
Serotonin blockade protects against early microvascular constriction following atherosclerotic plaque rupture.
Topics: Animals; Arteriosclerosis; Blood Flow Velocity; Disease Models, Animal; Iliac Artery; Indans; Microcirculation; Rabbits; Receptors, Serotonin, 5-HT2; Ritanserin; Rupture; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction | 2004 |